Specifically in glioma, the PD-1/PD-L1 axis is a critical element of immunosuppression within the TME, inhibiting T-cell activation and promoting Treg survival, while glioma cells enhance PD-L1 expression in myeloid cells and Tregs. The gene discussed is PDCD1; the disease is central nervous system cancer.